NASDAQInformation TechnologySolarSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for SMXT yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Expand EPC project portfolio revenue | The company aims to expand this portfolio to drive more sales. | Intact | annual revenue falls below $60M in FY26 | Revenue: $10.244M FY2026-Q2; GAAP. Published target: >= $90M annual revenue by FY26. Annual target cannot be compared with a quarterly or TTM observation. Oct 8, 202610,243,612 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 13, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earningsObserved price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a high-risk growth business with loss-making earnings, not yet a proven durable compounder. The long-term thesis is in a watch state: revenue and gross profit have grown, but recent momentum has weakened sharply.
The valuation evidence describes SMXT as cheap versus peers, but model confidence is low and the company is loss-making, so that comparison is uncertain. The evidence does not specify what expectations the market already assumes; muted share-price reaction does not resolve that gap.
Near-term, management’s focus on expanding its EPC project portfolio and improving margins has shown progress, with strong year-over-year revenue growth and higher gross profit in 2026-Q2. However, recent financial performance is weak, momentum fell sharply, and listing compliance remains pending after regulatory notices and a reverse stock split.
The multi-year thesis depends on continued project growth translating into better margins and stronger financial performance, while management addresses listing compliance. Near-term, a guidance cut would be a meaningful negative; easing interest rates or steadier results and guidance from sector peers could provide support, but the evidence does not establish that either will occur.
Over the next 1 to 3 years, SMXT’s growth progress is counterbalanced by losses, weak recent performance, and high execution and compliance risk. The long-term thesis remains uncertain and depends on sustained operating progress. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated in 1 of 2 supplied quarters. Management reported: “David Hsu, CEO of SolarMax, stated, “We delivered exceptional top-line growth in fiscal 2025, with revenue increasing nearly 300% year-over-year as we began recognizing contributions from our expanding engineering, procurement and construction (“EPC”) project portfolio.” “Our focus remains on our engineering, procurement and construction (“EPC”) projects, managing costs carefully and pursuing additional opportunities in large-scale energy storage.” Revenue was $10.244 million in 2026-Q2.
Stabilize management and governance | A supporting condition in SolarMax Technology Inc's published investment case. The stated target is No further key management departures in next 4 quarters. | Intact | Additional key management departures occur within next 4 quarters | 0 key departures vs 0 allowed News feed empty for management events. Recent 8-Ks cover earnings, delisting notice, and rights modifications, with no executive departures reported. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Regain Nasdaq listing compliance | If it regains Nasdaq compliance, it can stabilize its market presence. | Under Pressure | Failure to regain Nasdaq compliance by end of 2026 | Nasdaq delisting notice received 2026-08-21 Nasdaq issued delisting notice on Aug 21, 2026, citing failure to file Form 10-Q for the quarter ended June 30, 2026. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 1 of 2 supplied quarters. Management reported: “The Reverse Stock Split is intended to support the Company’s effort to regain compliance with the minimum bid price requirement for maintaining the listing of its Common Stock on the Nasdaq Capital Market.” Delivery assessment Nov 4, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
2 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.